default author photo

Anna Olsson-Brown

University Hospitals Sussex NHS Foundation Trust

SCHOLARLY PAPERS

2

DOWNLOADS

88

TOTAL CITATIONS

2

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

The Association of Pre-Existing Autoimmune Disease with Immune Related Adverse Events Secondary to Immune Checkpoint Inhibition Therapy in a Large Multi-Centre UK Population

Number of pages: 18 Posted: 05 Aug 2024
Anna Olsson-Brown, Mark Baxter, C Dobeson, L Feeney, Rebecca Lee, Alec Maynard, A Gault, M Rowe, S Mughal, S Parikh, LJ Rodgers, A Salawu, Rohan Shotton, Nadina Tinsley, J Heseltine, J Cotton, DJ Hughes, Angelos Angelakas, H Dearden, J Parry, SS Zhao, Ann Tivey, S Mirza and Christopher Jones
University Hospitals Sussex NHS Foundation Trust, University of Dundee, affiliation not provided to SSRN, Belfast Health and Social Care Trust, affiliation not provided to SSRN, Sheffield Teaching Hospitals NHS Foundation Trust, affiliation not provided to SSRN, Royal Cornwall Hospitals NHS Trust, affiliation not provided to SSRN, Leeds Teaching Hospitals NHS Trust, Beatson Institute for Cancer Research, Sheffield Teaching Hospitals NHS Foundation Trust, affiliation not provided to SSRN, Manchester Academic Health Sciences Centre - The Christie NHS Foundation Trust, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Leeds Teaching Hospitals NHS Trust, affiliation not provided to SSRN, affiliation not provided to SSRN, The University of Manchester, NHS Foundation Trust - Bradford Teaching Hospitals NHS Foundation Trust and University of Cambridge - Department of Oncology
Downloads 64 (924,743)
Citation 2

Abstract:

Loading...

oncological immune checkpoint inhibitors, pre-existing autoimmune disease, immune related adverse events, predisposition, autoimmune, autoinflammatory, Malignant melanoma, renal cell carcinoma, Non-Small Cell Lung Cancer, immunotherapy

2.

Impact of concurrent CMV colitis on clinical outcomes in immune checkpoint inhibitor‒induced colitis

Number of pages: 42 Posted: 06 Mar 2026
Hajir Ibraheim, Paolo Davide d’Arienzo, Nathan James Dean, William Duggleby, Ashish Singh, Thubeena Manickavasagar, Foteini Kalofonou, Mohamed Aboulela, Sree Vadera, Kirsty Ellen Anderson, Michael Campbell, Jacob Lewis, Paula Muehlshlegel, Stephanie Mullings, Jake James Symington, Sabeera Dar, Irene Oommen, Jenna Saad Hafidh, Robert Goldin, James L. Alexander, Anna Olsson-Brown, Kate Young and Nick Powell
Imperial College London - Division of Digestive Diseases, affiliation not provided to SSRN, affiliation not provided to SSRN, Sheffield Teaching Hospitals NHS Foundation Trust, affiliation not provided to SSRN, affiliation not provided to SSRN, NHS Foundation Trust - Royal Marsden Hospital, NHS Foundation Trust - Royal Marsden Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Government of the United Kingdom - Royal Free London NHS Foundation Trust, NHS Foundation Trust - Royal Marsden Hospital, affiliation not provided to SSRN, affiliation not provided to SSRN, Imperial College London, affiliation not provided to SSRN, Imperial College London, Imperial College London - Department of Metabolism, Digestion and Reproduction, University Hospitals Sussex NHS Foundation Trust, NHS Foundation Trust - Royal Marsden Hospital and Imperial College London - Department of Metabolism, Digestion and Reproduction
Downloads 24 (1,436,435)

Abstract:

Loading...

CMV, immunotherapy-related toxicity, immune-related adverse events, colitis.